<SEC-DOCUMENT>0001193125-20-177095-index.html : 20200624 <SEC-HEADER>0001193125-20-177095.hdr.sgml : 20200624 <ACCEPTANCE-DATETIME>20200624074801 ACCESSION NUMBER: 0001193125-20-177095 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20200624 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200624 DATE AS OF CHANGE: 20200624 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 20983882 BUSINESS ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>d949145d8k.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: d949145d8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-2.1 <SEQUENCE>2 <FILENAME>d949145dex21.htm <DESCRIPTION>EX-2.1 <TEXT> Document 2 - file: d949145dex21.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>3 <FILENAME>d949145dex101.htm <DESCRIPTION>EX-10.1 <TEXT> Document 3 - file: d949145dex101.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.2 <SEQUENCE>4 <FILENAME>d949145dex102.htm <DESCRIPTION>EX-10.2 <TEXT> Document 4 - file: d949145dex102.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.3 <SEQUENCE>5 <FILENAME>d949145dex103.htm <DESCRIPTION>EX-10.3 <TEXT> Document 5 - file: d949145dex103.htm
</DOCUMENT> </SEC-DOCUMENT>